Preparing to Scale Oxitec’s 2nd Generation Aedes aegypti Technology in Resource-limited, Dengue-prone Urban Settings
In plain English
AI plain-English summaryOxitec is preparing to scale up its second-generation genetically modified *Aedes aegypti* mosquito technology for use in dengue-prone cities where resources are limited. More than half the world’s population lives where *Aedes aegypti* mosquitoes are present, yet the newest, most targeted control tools remain financially and operationally out of reach for the communities that need them most. Meanwhile, the mosquito is expanding its geographical range and growing resistant to conventional insecticides. This project aims to close that gap by turning nearly a decade of research and development into a proven, affordable, and integrated solution. If successful, this work could transform how low-resource urban settings manage dengue and other mosquito-borne diseases. Instead of relying solely on insecticides that are losing effectiveness, governments and communities could deploy a simple, cost-effective biological control tool that targets only *Aedes aegypti*. The technology is designed to be accessible to a broad range of end-users, potentially shifting the burden of disease control from centralised programmes to local action.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Innovations Priority ProjectPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know